Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 2
1986 1
1987 1
1989 1
1990 2
1991 1
1992 2
1993 5
1994 3
1995 3
1996 2
1997 3
1998 6
1999 7
2000 6
2001 6
2002 12
2003 23
2004 21
2005 27
2006 25
2007 25
2008 33
2009 45
2010 53
2011 51
2012 62
2013 65
2014 89
2015 111
2016 124
2017 115
2018 130
2019 145
2020 179
2021 214
2022 279
2023 95

Text availability

Article attribute

Article type

Publication date

Search Results

1,780 results

Results by year

Filters applied: . Clear all
Page 1
Sintilimab versus placebo in combination with chemotherapy as first line treatment for locally advanced or metastatic oesophageal squamous cell carcinoma (ORIENT-15): multicentre, randomised, double blind, phase 3 trial.
Lu Z, Wang J, Shu Y, Liu L, Kong L, Yang L, Wang B, Sun G, Ji Y, Cao G, Liu H, Cui T, Li N, Qiu W, Li G, Hou X, Luo H, Xue L, Zhang Y, Yue W, Liu Z, Wang X, Gao S, Pan Y, Galais MP, Zaanan A, Ma Z, Li H, Wang Y, Shen L; ORIENT-15 study group. Lu Z, et al. Among authors: cui t. BMJ. 2022 Apr 19;377:e068714. doi: 10.1136/bmj-2021-068714. BMJ. 2022. PMID: 35440464 Free PMC article. Clinical Trial.
Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy.
Liu Y, Xun Z, Ma K, Liang S, Li X, Zhou S, Sun L, Liu Y, Du Y, Guo X, Cui T, Zhou H, Wang J, Yin D, Song R, Zhang S, Cai W, Meng F, Guo H, Zhang B, Yang D, Bao R, Hu Q, Wang J, Ye Y, Liu L. Liu Y, et al. Among authors: cui t. J Hepatol. 2023 Apr;78(4):770-782. doi: 10.1016/j.jhep.2023.01.011. Epub 2023 Jan 26. J Hepatol. 2023. PMID: 36708811
Clinical and biomarker analyses of sintilimab versus chemotherapy as second-line therapy for advanced or metastatic esophageal squamous cell carcinoma: a randomized, open-label phase 2 study (ORIENT-2).
Xu J, Li Y, Fan Q, Shu Y, Yang L, Cui T, Gu K, Tao M, Wang X, Cui C, Xu N, Xiao J, Gao Q, Liu Y, Zhang T, Bai Y, Li W, Zhang Y, Dai G, Ma D, Zhang J, Bai C, Huang Y, Liao W, Wu L, Chen X, Yang Y, Wang J, Ji S, Zhou H, Wang Y, Ma Z, Wang Y, Peng B, Sun J, Mancao C. Xu J, et al. Among authors: cui t. Nat Commun. 2022 Feb 14;13(1):857. doi: 10.1038/s41467-022-28408-3. Nat Commun. 2022. PMID: 35165274 Free PMC article. Clinical Trial.
Correspondence.
Fang X, Cui T, Qiu J, Zhang W, Duan H. Fang X, et al. Among authors: cui t. Retina. 2021 Sep 1;41(9):e53. doi: 10.1097/IAE.0000000000003172. Retina. 2021. PMID: 33814537 No abstract available.
A digital mask to safeguard patient privacy.
Yang Y, Lyu J, Wang R, Wen Q, Zhao L, Chen W, Bi S, Meng J, Mao K, Xiao Y, Liang Y, Zeng D, Du Z, Wu Y, Cui T, Liu L, Iao WC, Li X, Cheung CY, Zhou J, Hu Y, Wei L, Lai IF, Yu X, Chen J, Wang Z, Mao Z, Ye H, Xiao W, Yang H, Huang D, Lin X, Zheng WS, Wang R, Yu-Wai-Man P, Xu F, Dai Q, Lin H. Yang Y, et al. Among authors: cui t. Nat Med. 2022 Sep;28(9):1883-1892. doi: 10.1038/s41591-022-01966-1. Epub 2022 Sep 15. Nat Med. 2022. PMID: 36109638 Free PMC article.
1,780 results